Söylemez and his coworkers (119) showed that compared with non-cancer subjects, EIF4A1 mRNA expression was decreased in the tumor tissues from CRC patients of stage I, III, and IV, but increased in stage II. This evidence concerns the gene EIF4A1 and neoplasm.